Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
28/07/2011 | 13:00 | PR Newswire (Canada) | Labopharm to host conference call Thursday, August 4, 2011 at 8:30 A.M. (ET) | NASDAQ:DDSS | Labopharm Inc. (MM) |
24/06/2011 | 12:04 | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:DDSS | Labopharm Inc. (MM) |
23/06/2011 | 23:30 | PR Newswire (Canada) | LABOPHARM ANNOUNCES REDUCTION OF ANGELINI LABOPHARM'S OLEPTRO™ SALES FORCE | NASDAQ:DDSS | Labopharm Inc. (MM) |
21/06/2011 | 23:04 | PR Newswire (US) | LABOPHARM ANNOUNCES INTENTION TO DELIST FROM NASDAQ | NASDAQ:DDSS | Labopharm Inc. (MM) |
04/05/2011 | 13:00 | PR Newswire (US) | LABOPHARM REPORTS FINANCIAL RESULTS FOR FIRST QUARTER 2011 | NASDAQ:DDSS | Labopharm Inc. (MM) |
29/04/2011 | 18:00 | PR Newswire (US) | LABOPHARM TO HOST CONFERENCE CALL WEDNESDAY, MAY 4, 2011 AT 8:30 A.M. (ET) | NASDAQ:DDSS | Labopharm Inc. (MM) |
29/04/2011 | 13:00 | PR Newswire (US) | LABOPHARM PROVIDES UPDATE ON STRATEGIC REVIEW PROCESS | NASDAQ:DDSS | Labopharm Inc. (MM) |
01/04/2011 | 23:00 | PR Newswire (US) | LABOPHARM RECEIVES NOTICE FROM NASDAQ REGARDING MINIMUM MARKET VALUE OF LISTED SECURITIES | NASDAQ:DDSS | Labopharm Inc. (MM) |
31/03/2011 | 23:13 | Edgar (US Regulatory) | Annual and Transition Report (foreign private issuer) (20-F) | NASDAQ:DDSS | Labopharm Inc. (MM) |
22/03/2011 | 14:00 | PR Newswire (Canada) | LABOPHARM ANNOUNCES WORKFORCE REDUCTION AND APPOINTMENT OF NEW CFO | NASDAQ:DDSS | Labopharm Inc. (MM) |
14/03/2011 | 12:00 | PR Newswire (US) | LABOPHARM ANNOUNCES APPOINTMENT OF NEW PRESIDENT & CEO | NASDAQ:DDSS | Labopharm Inc. (MM) |
24/02/2011 | 13:00 | PR Newswire (US) | LABOPHARM REPORTS PROGRESS AND FINANCIAL RESULTS FOR FOURTH QUARTER 2010 | NASDAQ:DDSS | Labopharm Inc. (MM) |
10/02/2011 | 16:40 | PR Newswire (US) | LABOPHARM TO HOST CONFERENCE CALL THURSDAY, FEBRUARY 24, 2011 AT 8:30 A.M. (ET) | NASDAQ:DDSS | Labopharm Inc. (MM) |
25/01/2011 | 14:00 | PR Newswire (US) | LABOPHARM ANNOUNCES EXECUTIVE APPOINTMENTS | NASDAQ:DDSS | Labopharm Inc. (MM) |
20/01/2011 | 15:46 | PR Newswire (Canada) | LABOPHARM RECEIVES HEALTH CANADA APPROVAL FOR OLEPTRO(TM): A NEW ONCE-DAILY ANTIDEPRESSANT FOR THE TREATMENT OF MAJOR DEPRESSIVE | NASDAQ:DDSS | Labopharm Inc. (MM) |
07/01/2011 | 22:32 | Edgar (US Regulatory) | Amended Report of Foreign Issuer (6-K/A) | NASDAQ:DDSS | Labopharm Inc. (MM) |
03/01/2011 | 13:00 | PR Newswire (Canada) | LABOPHARM MONETIZES ROYALTY STREAM FROM PURDUE FOR RYZOLT(TM) | NASDAQ:DDSS | Labopharm Inc. (MM) |
31/12/2010 | 22:30 | PR Newswire (US) | LABOPHARM RECEIVES NOTICE FROM NASDAQ REGARDING MINIMUM BID PRICE REQUIREMENT | NASDAQ:DDSS | Labopharm Inc. (MM) |
12/11/2010 | 13:20 | PR Newswire (Canada) | LABOPHARM RECEIVES NOTICE OF ANDA SUBMISSION WITH PARAGRAPH IV CERTIFICATION FOR GENERIC OF OLEPTRO™ | NASDAQ:DDSS | Labopharm Inc. (MM) |
11/11/2010 | 13:23 | PR Newswire (US) | LABOPHARM REPORTS RESULTS FOR THIRD QUARTER 2010 | NASDAQ:DDSS | Labopharm Inc. (MM) |
28/10/2010 | 13:00 | PR Newswire (Canada) | LABOPHARM TO HOST CONFERENCE CALL THURSDAY, November 11, 2010 AT 8:30 A.M. (ET) | NASDAQ:DDSS | Labopharm Inc. (MM) |
14/10/2010 | 13:00 | PR Newswire (US) | LABOPHARM AND PALADIN ANNOUNCE EXPANSION OF COMMERCIAL RELATIONSHIP | NASDAQ:DDSS | Labopharm Inc. (MM) |
13/10/2010 | 15:42 | PR Newswire (Canada) | LABOPHARM'S TWICE-DAILY TRAMADOL-ACETAMINOPHEN APPROVED IN EUROPE | NASDAQ:DDSS | Labopharm Inc. (MM) |
12/08/2010 | 13:00 | PR Newswire (US) | Labopharm Reports Results for Second Quarter 2010 | NASDAQ:DDSS | Labopharm Inc. (MM) |
10/08/2010 | 15:00 | PR Newswire (US) | Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults | NASDAQ:DDSS | Labopharm Inc. (MM) |
06/08/2010 | 17:00 | PR Newswire (US) | Labopharm to present at Canaccord Genuity 30th Annual Growth Conference | NASDAQ:DDSS | Labopharm Inc. (MM) |
29/07/2010 | 13:00 | PR Newswire (US) | Labopharm to host conference call Thursday, August 12, 2010 at 8:30 A.M.(ET) | NASDAQ:DDSS | Labopharm Inc. (MM) |
09/07/2010 | 13:00 | PR Newswire (US) | Labopharm Announces Amendment to Debt Facility Agreement with Hercules | NASDAQ:DDSS | Labopharm Inc. (MM) |
04/06/2010 | 13:45 | PR Newswire (US) | Labopharm comments on judgment in Purdue appeal of decision relating to patents | NASDAQ:DDSS | Labopharm Inc. (MM) |
20/05/2010 | 22:02 | PR Newswire (US) | Labopharm announces completion of joint venture with Angelini | NASDAQ:DDSS | Labopharm Inc. (MM) |